Elie Iatcheva
About Elie Iatcheva
Elie Iatcheva is the Medical Director at Novocure in Paris, with extensive experience in the pharmaceutical and biotechnology industries, having previously worked at PTC Therapeutics, CHIESI France, Meda Pharma, Chiron Corporation, Roche Pharmaceuticals, and AP-HP.
Current Role at Novocure
Elie Iatcheva holds the position of Medical Director at Novocure, based in Paris, Île-de-France, France. In this capacity, Iatcheva is responsible for overseeing and guiding medical strategies, ensuring compliance with regulatory requirements, and leading clinical trials and medical research initiatives. Novocure specializes in the development of treatments for cancer, and Iatcheva's role is crucial for the advancement of the company's mission to extend patient survival.
Previous Positions and Experience
Elie Iatcheva has built a substantial career in the medical and pharmaceutical industries, having served in various high-level positions. From 2017 to 2020, Iatcheva worked as Director of Medical Affairs at PTC Therapeutics, Inc. Prior to this, from 2015 to 2017, Iatcheva was the Directeur des Affaires Médicales at CHIESI France. Earlier roles include serving as Directeur Médical at Meda Pharma from 2006 to 2015, and at Chiron Corporation from 2000 to 2006. Iatcheva began their career as Chef de projets at Roche Pharmaceuticals from 1998 to 2000 and as Médecin praticien at AP-HP, Assistance Publique - Hôpitaux de Paris from 1991 to 2000.
Education and Medical Training
Elie Iatcheva received medical training at the Académie de médecine, where Iatcheva studied Pédiatrie and pneumologie pédiatrique, ultimately earning a Docteur de médecine. This educational background provided a foundation in pediatric pulmonology, which has informed Iatcheva's subsequent specialization in various therapeutic areas.
Clinical Trials and Research Contributions
Elie Iatcheva has extensive experience in managing clinical trials from Phase IIIb to Phase IV. This includes significant contributions to the research and development processes across multiple therapeutic areas such as rare diseases, respiratory and allergy, dermatology, gene therapy, neurodegenerative diseases, internal medicine, cancer pain, primary care, infectious diseases, and the OTC market. Iatcheva's work has supported the advancement of medical knowledge and the development of new treatments.
Expertise in Pharmaceutical and Biotechnology Industries
With a deep experience in the pharmaceutical and biotechnology industries, Elie Iatcheva has demonstrated agility in various Medical Director roles. These roles have included responsibilities in market access, marketing, and commercialization activities. Iatcheva's background as a paediatric pulmonologist and extensive management skills in clinical trials have made significant contributions to the organizations served.